Latka logo

How CancerIQ CEO Feyi Ayodele grew CancerIQ to $9.2M revenue with a 39 person team in 2024.

Provider of a Web-based digital application designed to allow oncologists collect genetic information from cancer patients and compare that information against a large database of similar patients. The company's application helps patients and physicians to identify risk factors caused due to cancer, genetics and other oncological problem, enabling doctors to identify high-risk patients and offer preventative treatment.

Last updated

CancerIQ Revenue

In 2024, CancerIQ's revenue reached $9.2M. The company previously reported $5.5M in 2023. Since its launch in 2013, CancerIQ has shown consistent revenue growth.

CancerIQ Revenue GrowthReported revenue / ARR by year$0$2M$4M$6M$8M$10M2013201520172019202120232024$0$2M$4M$6M$9MSource: GetLatka.com
YearMilestone
2024CancerIQ Hit $9.2m revenue in October 2024
2023CancerIQ Hit $5.5m revenue in November 2023
2022CancerIQ Hit $4m revenue in November 2022
2022CancerIQ Hit $4m revenue in March 2022
2021CancerIQ Hit $1.7m revenue in November 2021
2021CancerIQ Hit $1.7m revenue in April 2021
2013Launched with $0 revenue

CancerIQ Valuation, Funding Rounds

CancerIQ has not publicly disclosed its valuation. The company has raised $20M in total funding to date.

CancerIQ has raised $20M in total funding across 3 rounds, most recently a $14M Series B round in 2022.

CancerIQ Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$5M$10M$15M$20M$25M2013201520172019202120222013 cumulative: $0 • 2013 Founded: $02014 cumulative: $1M • 2013 Founded: $0 • 2014 Convertible Note: $1M2020 cumulative: $6M • 2013 Founded: $0 • 2014 Convertible Note: $1M • 2020 Series A: $5M2022 cumulative: $20M • 2013 Founded: $0 • 2014 Convertible Note: $1M • 2020 Series A: $5M • 2022 Series B: $14M$20M2013 Founded: $0 valuationSource: GetLatka.com
YearRoundAmountValuation% Sold
2022Series B$14M--
2020Series A$4.8M--
2014Convertible Note$1.2M--

CancerIQ Employees & Team Size

CancerIQ employs approximately 39 people as of 2026, down from 46 in 2023.

CancerIQ has 39 total employees in different roles and functions and 9 sales reps that carry a quota.

CancerIQ Team GrowthReported headcount over time010203040502013201520172019202120232024003939Source: GetLatka.com
YearMilestone
2024Reached 39 employees (December 2024)
2024Reached 37 employees (October 2024)
2023Reached 46 employees (November 2023)
2022Reached 33 employees (November 2022)
2022Reached 33 employees (March 2022)
2021Reached 20 employees (November 2021)
2021Reached 20 employees (April 2021)
2020Reached 18 employees (November 2020)

Founder / CEO

Feyi Ayodele

Founder and CEO at Cancer IQ Inc. Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse respectively. Her journey with Cancer IQ began in 2012, when Feyi wanted to be more of a participant in the healthcare sector than a bystander. On a family trip to climb Mount Kilimanjaro, she hatched a plan to defer her position at McKinsey and commercialize the work of her mother, a renowned medical oncologist. While at University of Chicago Medicine, Feyi witnessed the most cutting edge clinical care, and identified a number of bottlenecks that constrained patient access to it. In 2013, CancerIQ was born. After recruiting a board of thought leading advisors spearheaded by her mother, she led the product design effort, raised capital, and recruited a team to help her flesh-out the concept. Since conceiving the concept, CancerIQ has garnered support from top accelerator programs, investors, and most importantly - customers. She leads the business development team at CancerIQ, and manages all strategic partnerships. She is a Chicago Booth New Venture Challenge winner, a Rock Health fellow, and winner of 1776’s Global Challenge Cup.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for CancerIQ yet.

Frequently Asked Questions about CancerIQ

What is CancerIQ's revenue?

CancerIQ generates $9.2M in revenue.

Who founded CancerIQ?

CancerIQ was founded by Feyi Ayodele.

Who is the CEO of CancerIQ?

The CEO of CancerIQ is Feyi Ayodele.

How much funding does CancerIQ have?

CancerIQ raised $20M.

How many employees does CancerIQ have?

CancerIQ has 39 employees.

Where is CancerIQ headquarters?

CancerIQ is headquartered in United States.

Compare CancerIQ to the industry

CancerIQ operates across multiple industries. Browse revenue, funding, and growth data for CancerIQ in each sector below.

Source Attribution

Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.

Company data last updated .

CancerIQ Revenue 2024: $9.2M ARR, $20M Raised